We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-1.53%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$23.8B
AUM Growth
-$2.11B
Cap. Flow
-$941M
Cap. Flow %
-3.95%
Top 10 Hldgs %
24.95%
Holding
1,082
New
165
Increased
347
Reduced
405
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 30.74%
2 Financials 13.54%
3 Consumer Discretionary 13.12%
4 Industrials 11.88%
5 Healthcare 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXS icon
401
AXIS Capital
AXS
$8.45B
$5.52M 0.02%
54,447
+50,098
+1,152% +$5.14M
IIIN icon
402
Insteel Industries
IIIN
$626M
$5.51M 0.02%
164,053
+2,594
+2% +$89K
VREX icon
403
Varex Imaging
VREX
$452M
$5.51M 0.02%
519,137
+18,389
+4% +$235K
MAT icon
404
Mattel
MAT
$4.14B
$5.44M 0.02%
+374,109
New +$6.82M
MSBI icon
405
Midland States Bancorp
MSBI
$642M
$5.41M 0.02%
242,550
+4,186
+2% +$93.5K
EXPD icon
406
Expeditors International
EXPD
$23B
$5.39M 0.02%
37,627
-554,423
-94% -$84.3M
GSM icon
407
FerroAtlántica
GSM
$626M
$5.37M 0.02%
1,303,260
+222,052
+21% +$1.07M
CTRN icon
408
Citi Trends
CTRN
$514M
$5.32M 0.02%
122,826
+250
+0.2% +$11.4K
AEE icon
409
Ameren
AEE
$31.3B
$5.28M 0.02%
+48,013
New +$5.13M
SPG icon
410
Simon Property Group
SPG
$73B
$5.18M 0.02%
27,795
-771
-3% -$147K
NI icon
411
NiSource
NI
$22.4B
$5.15M 0.02%
+110,305
New +$4.97M
SNDK
412
Sandisk
SNDK
$238B
$5.14M 0.02%
8,087
-8,901
-52% -$5.03M
YELP icon
413
Yelp
YELP
$1.35B
$5.08M 0.02%
205,316
+18,111
+10% +$459K
MRNA icon
414
Moderna
MRNA
$22.6B
$5.08M 0.02%
99,952
-116,524
-54% -$5.44M
EQH icon
415
Equitable Holdings
EQH
$12.9B
$5.06M 0.02%
+136,228
New +$5.84M
REAX icon
416
Real Brokerage
REAX
$364M
$5.05M 0.02%
2,020,504
+110,193
+6% +$333K
MAGN
417
Magnera Corp
MAGN
$472M
$4.99M 0.02%
524,890
-261,193
-33% -$3.34M
OMDA
418
Omada Health Inc
OMDA
$1.26B
$4.97M 0.02%
395,238
+327,981
+488% +$4.53M
ALLO icon
419
Allogene Therapeutics
ALLO
$628M
$4.91M 0.02%
+2,013,508
New +$4.04M
KURA icon
420
Kura Oncology
KURA
$928M
$4.9M 0.02%
602,231
-1,420,102
-70% -$12.2M
ASIX icon
421
AdvanSix
ASIX
$577M
$4.84M 0.02%
198,296
-1,665
-0.8% -$31.4K
HAFC icon
422
Hanmi Financial
HAFC
$959M
$4.83M 0.02%
183,322
+20,313
+12% +$547K
SLDE
423
Slide Insurance Holdings
SLDE
$2.26B
$4.81M 0.02%
267,455
+161,105
+151% +$2.82M
DAKT icon
424
Daktronics
DAKT
$957M
$4.79M 0.02%
245,047
AGNT
425
AGNT Inc
AGNT
$636M
$4.78M 0.02%
797,732
-154,355
-16% -$1.19M

Similar funds

Jacobs Levy Equity Management's Q1 2026 Portfolio in Review

As of Q1 2026, Jacobs Levy Equity Management held 1,082 positions worth $23.8B, down 8.1% from $25.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Jacobs Levy Equity Management withdrew a net $941M in Q1 2026, closing 129 positions and reducing 405 holdings. Its most notable exit was Illumina, an estimated $53.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Jacobs Levy Equity Management opened a new position in Texas Instruments worth $166M.

  • Jacobs Levy Equity Management's largest Q1 2026 buy was Texas Instruments: 857,024 shares worth $166M.
  • Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q1 2026, an estimated $293M increase.
  • Jacobs Levy Equity Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $284M.
  • Jacobs Levy Equity Management fully exited Illumina in Q1 2026, selling an estimated $53.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 25% of its $23.8B portfolio in Q1 2026.
  • Jacobs Levy Equity Management opened 165 new positions and closed 129 in Q1 2026.
  • Jacobs Levy Equity Management's portfolio value fell 8.1% quarter-over-quarter to $23.8B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.